Home › Borstkanker › Arizona › Tucson
Borstkanker klinische studies in Tucson, AZ
20 studies voor Borstkanker zoeken deelnemers op locaties in en rond Tucson (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
RekruterenFase 3
- The University of Arizona Cancer Center - North Campus ( Site 0055), Tucson
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekruterenFase 2
- The University of Arizona Cancer Center - North Campus, Tucson
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruterenFase 3
- University of Arizona Cancer Center ( Site 0035), Tucson
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Rekruteren
- University of Arizona Cancer Center, Tucson
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruterenFase 3
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- Arizona Clinical Research Center, Inc., Tucson
- University of Arizona Cancer Center, Tucson
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
RekruterenFase 1/2
- University of Arizona Cancer Center, Tucson
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
RekruterenFase 1/2
- University of Arizona, Tucson
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruterenFase 3
- University of Arizona-Cancer Center, Tucson
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruterenFase 3
- Tucson Medical Center HealthCare, Tucson
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruterenFase 1/2
- USOR Arizona Oncology Associates, Tucson
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
RekruterenFase 2
- University of Arizona Cancer Center - Prevention Research Clinic, Tucson
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
RekruterenFase 3
- University of Arizona - Cancer Center, Tucson
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruterenFase 1
- The University of Arizona Cancer Center, Tucson
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
RekruterenFase 1
- The University of Arizona Cancer Center, Tucson
High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
RekruterenGezonde vrijwilligers welkom
- University of Arizona, Tucson
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekruterenObservatieonderzoek
- Arizona Oncology Associates, PC - HOPE, Tucson
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
RekruterenFase 2
- Arizona Oncology Associates, Tucson
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
Rekruteren
- University of Arizona, Tucson
CtDNA Based MRD Testing for NAC Monitoring in TNBC
RekruterenObservatieonderzoek
- Arizona Oncology, Tucson
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Tucson
- Obesitas18 studies
- Niet-kleincellige longkanker17 studies
- Overgewicht15 studies
- Metastatische kanker14 studies
- Kanker (alle vormen)12 studies
- Cardiovasculaire ziekte12 studies
- Colorectale kanker11 studies
- Prostaatkanker11 studies
- Type 2-diabetes11 studies
- Steatotische leveraandoening10 studies
- Hartfalen10 studies
- Hoge bloeddruk10 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.